28
Oct
2025

Adare Pharma Solutions

Exhibitor at CPHI Frankfurt 2025 stand 5.1C42, Contract Manufacturing and Services
About Us

Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms. Adare’s specialized technology platforms provide taste masking, customized release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare's seven facilities in the US and Europe have developed and manufactured more than 65 products sold by customers worldwide. 

  • US
  • 2015
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Service
Packaging supplier/manufacturer
Primary activities
Contract Manufacturer
Out-licensing specialist
Packaging & drug delivery
Contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 5.1C42, Contract Manufacturing and Services

Products Featured at CPHI Frankfurt 2025

  • Manufacturing Capabilities

    Product Manufacturing Capabilities

    Standard Offerings 
    • Granulation & Mixing  • Fluid Bed Processing & Drying • Hot Melt Extrusion  • Pan Coating  • Blending  • Tableting  • Multi-layer Tablets  • Capsule Filling  • Oven Drying  • Small-scale GMP Manufacturing ...
  • Development Services

    Product Development Services

    Comprehensive R&D Services   • Preformulation • Formulation Development of Solid Dose Tablets (Capsules, Liquids & Solutions) • Pediatric Formulation • Product Design • Formulation Optimization • Sourcing of APIs & Excipients • Analytical Method Development & Validation • ...
  • Technologies

    Product Technologies

    Adare’s industry-leading experts possess unparalleled experience in the development of unique dosage forms that provide taste masking, customized release, and patient-centric solutions. Our technology platforms overcome complex formulation challenges to improve the lives of all patients, with expertise in ...
  • Packaging

    Product Packaging

    Clinical & Commercial Packaging Services
    • Two FDA-Registered Packaging Facilities  • A Full Range of Solid-Dose Packaging Solutions • High-Speed Bottle Filling  • Blister Packaging  • Stick Pack & Cartoning Operations • Packaging of DEA Schedules II, 2N, III, 3N, IV, L1 • Thermo &...
  • Nitrosamine Mitigation

    Product Nitrosamine Mitigation

    Very few CDMOs can claim Adare's level of experience in mitigating the presence of nitrosamine. We can employ our own-in-house mitigation processes to develop the best long-term control strategies for your product. 

    Regain control of your product with NitroCLEARx • Receive real-world mitiga...
  • Adaptdose™

    Product Adaptdose™

    Adaptdose™, Adare’s unique commercialized approach to adaptive formulation design, is a highly flexible, multi-delivery platform tool that eliminates the need for post Phase 1 trial reformulations and facilitates the creation of custom oral delivery systems. Adaptdose provides the ability to combine 2-3 ac...
  • CAT.one SM

    Product CAT.one SM

    CAT.one SM minimizes the potential for abuse by ensuring that drug products are evaluated for all potential routes of misuse. Adare’s experts integrate abuse-deterrent testing by replicating basic and multi-step methods that an abuser may use to prepare the product for recreational misuse or abuse. Our CAT...
  • DIFFUTAB® Technology

    Product DIFFUTAB® Technology

    DIFFUTAB® technology is an effective solution for targeted drug delivery through customized and sustained release. The technology assists the development of high-dosage and sustained release products for once-daily administration. A matrix tablet is coated with functional polymers, followed by a blend of h...
  • Duragran™

    Product Duragran™

    Duragran™ allows for more uniformity and precise control of targeted particle sizes while providing production time and cost savings. It eliminates the need for extrusion and spheronization for high API-loaded drug particulates by using fluid bed processing technology that combines the particle sizing and ...
  • Microcaps® Taste Masking and Modified Release Technology

    Product Microcaps® Taste Masking and Modified Release Technology

    Microcaps® Taste Masking and Modified Release Technology achieves uniform and efficient coating of drug particles by coacervation (phase separation) to build polymeric membranes of varying porosity and thickness. The result is a free-flowing powder containing microencapsulated API (or API substrate) in a w...
  • Precision Particle Fabrication™ Technology

    Product Precision Particle Fabrication™ Technology

    Precision Particle Fabrication™ technology produces uniform microspheres and microcapsules with narrow size distribution and precise control over particle structure. The platform technology is flexible and customizable to accommodate a broad range of active ingredients, including small molecules, peptides ...
  • Optimµm® Technology for Oral Delivery

    Product Optimµm® Technology for Oral Delivery

    The Optimµm® technology creates microspheres with high drug loading suitable for taste masking, enteric coatings, and extended release oral applications. The technology is capable of producing single- or double-layer particles in a one manufacturing step, lending to cost-effective creation of palatabl...
  • Stratµm™ Technology for Injectable Delivery

    Product Stratµm™ Technology for Injectable Delivery

    The Stratµm™ technology, for injectable delivery, allows for precise control of particle size and composition enabling predictable injectable performance, which is critical for self-administration, extended release, and modified release applications with a narrow therapeutic index. Unlike other encapsu...
  • Unisun® Technology for Otic Delivery

    Product Unisun® Technology for Otic Delivery

    The Unisun® technology combines the use of encapsulated or free drug, along with a fast-film forming agent, which allows for low-cost, long-acting intratympanic delivery of a therapeutic. The technology allows for less frequent administrations than current therapies and is capable of sustaining drug le...